Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary Intervention
2002; American Medical Association; Volume: 288; Issue: 19 Linguagem: Inglês
10.1001/jama.288.19.2411
ISSN1538-3598
AutoresSteven R. Steinhubl, Peter B. Berger, J. Tift Mann, Edward T.A. Fry, Augustin DeLago, Charles Wilmer, Eric J. Topol, for the CREDO Investigators,
Tópico(s)Atrial Fibrillation Management and Outcomes
ResumoSPIRIN IS A CORNERSTONE OF therapy for patients undergoing coronary intervention.Its use is considered a standard of care before the procedure and lifelong following revascularization.2][3][4] However, the optimal timing for the initiation of clopidogrel and aspirin, as well as their duration of treatment following a PCI procedure, remains unknown.][7] Despite the consistency of this observation, patient or procedural characteristics may have biased the results in
Referência(s)